CELL INTELLIGENCE · 肿瘤细胞治疗研究

用于乳腺癌治疗的可注射水凝胶：从肿瘤微环境响应性与主动靶向药物递送到免疫治疗与诊疗一体化

Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

嵌合抗原受体自然杀伤（CAR-NK）细胞治疗乳腺癌的疗效与安全性评价：系统综述与荟萃分析

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.

抗 HER2 亲和体导向的 CAR-NK 的构建及其与负载多柔比星的纳米药物抗 HER2 阳性乳腺癌的协同作用

Construction of anti-HER2 affibody-directed CAR-NK and its synergistic effects with doxorubicin-loaded nanodrug against HER2-positive breast cancer.

这些发现表明，基于亲和体的 CAR-NK 细胞是传统基于 scFv 的 CAR 结构的可行替代方案。

嵌合抗原受体 NK 细胞用于乳腺癌免疫治疗

Chimeric antigen receptor NK cells for breast cancer immunotherapy.

mRNA 递送在肿瘤免疫治疗中的应用

Applications of mRNA Delivery in Cancer Immunotherapy.

耐受 H2O2 和缺氧的工程化 CAR-NK 细胞抑制三阴性乳腺癌术后复发

Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers.

乳腺癌 CAR 免疫治疗：特殊性、在研探索与未来策略

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies.

乳腺癌中基于嵌合抗原受体的免疫治疗：中国近期进展

Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China.

工程化 CAR-NK 细胞来源外泌体伪装纳米炸弹增强 HER2 阳性乳腺癌脑转移治疗

Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy.